stockrow
Monday 9 November 2026
Export RMTI’s income statement to Excel — free account
Rockwell Medical, Inc.
RMTIHealthcare Drug Manufacturers Specialty & Generic
Rockwell Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.3 million, down 31.8% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +32.0%
- Free cash flow
- −12.9%
- Total debt
- −1.73%
Quarter to June 2026, against a year earlier
7.73
0.13
+1.71%
Follow RMTI
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | 7 | 4 | 6 | 1 | 3 | 3 | 3 | 3 | 3 |
P/S ratio |
0.43 | 0.62 | 0.64 | 0.20 | 0.62 | 1.23 | 2.42 | 1.88 | 5.03 | 6.12 |
Altman Z-Score |
(7.44) | (5.76) | (8.34) | (10.58) | (10.60) | (4.56) | (6.49) | (4.49) | 1.50 | 3.81 |
Altman Z″-Score (non-manufacturers) |
(18.33) | (18.00) | (23.43) | (26.66) | (27.04) | (11.00) | (23.27) | (15.71) | (10.52) | (2.80) |
P/FCF ratio |
0.00 | 127.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
13.10 | 73.25 | (1,250.70) | (131.55) | (4.26) | (8.91) | (28.05) | (20.64) | (59.87) | 606.70 |
Beneish M-Score |
(2.80) | (3.16) | (1.62) | (3.44) | — | (2.75) | (4.27) | — | (1.43) | (2.14) |
P/B ratio |
0.81 | 1.94 | 2.53 | 1.04 | 15.17 | 2.24 | 7.32 | 4.38 | 8.75 | 6.16 |
Price to Tangible BV |
1.14 | 2.95 | 5.60 | 1.12 | 23.82 | 2.30 | 7.66 | 4.53 | 9.00 | 6.27 |
EV/Sales |
0.29 | 0.56 | 0.70 | 0.06 | 0.59 | 0.64 | 2.07 | 1.54 | 4.66 | 5.26 |
EV/EBITDA |
0.00 | 17.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(29.99) | 13.52 | (6.20) | (0.27) | (1.09) | (1.34) | (4.65) | (4.79) | (12.65) | (22.52) |
EV/FCF |
(5.07) | 114.52 | (4.71) | (0.23) | (1.00) | (1.19) | (4.15) | (4.10) | (10.47) | (18.09) |
Quick Ratio |
3.46 | 2.12 | 1.31 | 1.57 | 1.35 | 4.91 | 2.44 | 3.10 | 4.31 | 6.34 |
Current Ratio |
3.98 | 2.63 | 1.73 | 2.00 | 1.68 | 5.43 | 2.98 | 3.55 | 5.34 | 7.74 |
Net Debt/EBITDA |
7.40 | (3.80) | 0.52 | 0.74 | 0.07 | 1.42 | 0.69 | 1.05 | 1.30 | 2.98 |
Debt/Assets |
15.98% | 15.88% | 18.85% | 24.20% | 42.37% | 28.45% | 9.11% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.25 | 0.29 | 0.46 | 0.80 | 8.12 | 0.65 | 0.20 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.19 | 1.82 | 1.69 | 1.53 | 0.98 | 1.02 | 1.27 | 1.14 | 0.81 | 0.62 |
Operating CF/Net income |
0.12 | (8.75) | 1.12 | 0.91 | 1.03 | 0.96 | 0.80 | 0.64 | 0.81 | 0.63 |
Capex/Depreciation |
(0.21) | (0.39) | (0.06) | (0.09) | (0.18) | (0.40) | (0.22) | (1.14) | (3.27) | (0.46) |
Interest Coverage |
(4.17) | 0.48 | (2.90) | (8.67) | (12.85) | (15.13) | (1,381.00) | (60.60) | (32.81) | (24.94) |
| (15.28%) | (1.78%) | (47.68%) | (224.49%) | (178.04%) | (113.38%) | (143.40%) | (106.75%) | (60.37%) | (34.36%) | |
| (9.13%) | (0.86%) | (17.08%) | (39.24%) | (51.73%) | (50.61%) | (70.46%) | (57.71%) | (36.53%) | (23.16%) | |
ROIC |
(13.89%) | 1.86% | (20.64%) | (268.77%) | (2,796.46%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(16.00%) | (1.67%) | (45.53%) | (94.28%) | (194.40%) | (52.08%) | (126.71%) | (88.60%) | (61.38%) | (28.39%) |
Average Days of Receivables |
42.91 | 29.82 | 47.59 | 31.38 | 34.85 | 24.48 | 25.02 | 42.33 | 40.48 | 43.79 |
Research and Development Expense of Revenue |
0.00% | 0.02% | 1.32% | 4.28% | 11.04% | 11.40% | 11.23% | 10.64% | 11.03% | 10.96% |
Selling, General and Administrative Expense of Revenue |
23.66% | 16.61% | 17.06% | 24.36% | 34.04% | 38.67% | 49.02% | 36.41% | 40.67% | 39.64% |
Intangible Assets out of Total Assets |
0.19 | 0.19 | 0.22 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
2.62% | 1.27% | 1.11% | 0.43% | 1.52% | 0.76% | 8.08% | 6.92% | 12.52% | 19.42% |
Graham Net Nets |
0.60 | 0.16 | (0.04) | 0.19 | (0.28) | 0.34 | 0.09 | 0.18 | 0.08 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(17.99%) | (0.98%) | (21.91%) | (164.60%) | (84.19%) | (40.60%) | (22.95%) | (28.32%) | (9.04%) | (6.21%) |
Free Cash Flow Yield |
(12.99%) | 0.78% | (23.04%) | (135.10%) | (95.58%) | (43.71%) | (20.54%) | (19.99%) | (8.85%) | (4.75%) |
Revenue per Share |
19.25 | 32.68 | 35.85 | 50.90 | 72.64 | 90.48 | 110.70 | 132.00 | 123.44 | 115.68 |
Operating CF per Share |
(0.18) | 1.35 | (4.04) | (11.83) | (39.33) | (43.12) | (49.21) | (42.52) | (45.48) | (27.04) |
Capex per Share |
(0.15) | (0.33) | (0.12) | (0.20) | (0.61) | (1.52) | (1.06) | (1.55) | (3.62) | (0.77) |
Free Cash Flow per Share |
(0.33) | 1.03 | (4.16) | (12.03) | (39.94) | (44.64) | (50.27) | (44.07) | (49.11) | (27.80) |
Cash per Share |
6.95 | 6.96 | 4.69 | 15.02 | 26.32 | 85.36 | 47.03 | 69.83 | 71.21 | 125.79 |
Shareholders Equity per Share |
10.28 | 10.49 | 9.13 | 9.86 | 2.97 | 49.71 | 36.69 | 56.80 | 70.90 | 114.97 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.28 | 10.49 | 9.13 | 9.86 | 2.97 | 49.71 | 36.69 | 56.80 | 70.90 | 114.97 |
Free Cash Flow |
(1.20) | 3.19 | (9.70) | (17.21) | (34.06) | (30.69) | (27.84) | (21.16) | (22.80) | (12.81) |
Working Capital |
28.58 | 22.94 | 12.13 | 17.62 | 14.32 | 56.68 | 24.50 | 33.62 | 39.69 | 68.36 |
Capital Expenditures |
(0.54) | (1.01) | (0.28) | (0.28) | (0.52) | (1.05) | (0.59) | (0.74) | (1.68) | (0.35) |
Net Current Asset Value |
18.00 | 10.41 | (2.11) | 2.78 | (10.75) | 25.89 | 12.88 | 21.54 | 22.96 | 48.31 |
EV/EBIT |
0.00 | 93.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 |
Price to Operating Income |
0.00 | 104.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.55 | 0.45 | 0.71 | 1.35 | 1.16 | 0.98 | 1.09 | 0.25 | 0.20 | 0.55 |
Cash ROIC |
(1.69%) | 5.02% | (23.05%) | (36.71%) | (74.76%) | (26.69%) | (55.24%) | (34.80%) | (34.55%) | (11.55%) |
Accounts Receivable Turnover |
8.43 | 10.58 | 9.75 | 11.96 | 12.28 | 14.85 | 10.61 | 9.25 | 8.99 | 9.32 |
Accounts Payable Turnover |
23.65 | 22.75 | 17.48 | 17.64 | 16.30 | 16.58 | 15.57 | 14.91 | 10.63 | 9.44 |
Inventory Turnover |
12.51 | 14.42 | 12.82 | 13.90 | 16.11 | 15.73 | 15.21 | 11.13 | 5.42 | 4.65 |
Average Days of Payables |
12.68 | 12.47 | 22.00 | 21.52 | 21.21 | 25.50 | 18.84 | 25.24 | 28.75 | 45.95 |
Days of Inventory on Hand |
21.71 | 25.11 | 28.61 | 30.87 | 23.12 | 24.02 | 22.77 | 22.69 | 52.01 | 95.24 |
Average Receivables |
8.22 | 9.60 | 8.58 | 6.09 | 5.04 | 4.19 | 5.78 | 6.85 | 6.37 | 5.72 |
Average Payables |
2.43 | 3.69 | 4.28 | 3.90 | 3.95 | 3.59 | 3.76 | 4.36 | 5.04 | 4.93 |
Average Inventory |
4.60 | 5.82 | 5.84 | 4.95 | 3.99 | 3.78 | 3.84 | 5.84 | 9.89 | 10.01 |
Average Assets |
58.18 | 55.69 | 49.40 | 47.60 | 63.16 | 61.03 | 48.44 | 55.67 | 70.97 | 85.49 |
Average Common Equity |
34.78 | 26.94 | 17.70 | 8.32 | 18.35 | 27.25 | 23.80 | 30.10 | 42.93 | 57.64 |
Columns are period end dates · fundamentals updated 26 Oct 2026